FDA slams Dollar Tree for purchasing drugs from suppliers with checkered safety records
Amid growing concerns over the pharmaceutical supply chain, regulators sternly warned the Dollar Tree (DLTR), which runs a vast network of stores serving mostly low-income communities, for selling over-the-counter medicines made by companies that failed to ensure the drugs were safely manufactured and tested.
In a Nov. 6 warning letter, the Food and Drug Administration noted the retailer purchased medicines from foreign companies that failed to follow manufacturing standards and displayed a pattern of serious violations. These included a failure to test raw materials and finished products, and falsifying test results and releasing sub-potent drugs to the U.S. market. One company had rodent feces throughout its facility, according to the letter, which was posted on the FDA website Thursday.